Several million individuals suffer from bone and joint dysfunction that adversely impacts individual quality of life, medical costs associated with treatment, and economic productivity to the individual, state and federal governments. Although advancements have been made in surgically correcting bone and joint disease with artificial prostheses, each procedure has inherent limitations. By regenerating natural tissue, tissue engineering offers significant advantages over artificial joint replacement. Due to these advantages, the economic and technology transfer benefits of tissue engineering are substantial. Business week (7-27-98) cited a study that $400 billion per year were spent to correct organ and tissue failure, half of the US national health care budget. We will develop a gene therapy-directed tissue reconstruction system based on rapid fabrication of designed scaffolds that deliver appropriate genes for bone and cartilage regeneration. This project integrates engineering techniques including imaging, computational design and 3-D micro/macro material fabrication with biological techniques of gene transfer and genetic engineering of mesenchymal stem cells to produce engineered materials/biologic constructs for tissue regeneration. These constructs will be able to regenerate tissues lost to trauma, congenital deformities and chronic degenerative disease. The hypothesis underlying this proposed study is that both bone and cartilage can be produced on a single bioengineered scaffold by gene transfer of appropriate morphogenetic signal in vivo. This hypothesis will be tested in two specific aims: 1) To develop materials/biologic constructs for gene therapy-induced bone and cartilage regeneration; and 2) To determine the relative efficacy of in vivo and ex vivo gene therapy strategies to gain spatial control over regeneration of bone and cartilage tissue as well as the corresponding bone-cartilage interface in bioengineered scaffolds. Bone and cartilage formation in our anatomic-specific designed bioengineered materials will facilitate innovative strategies for the reconstruction of human joints.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AR048414-01
Application #
6441325
Study Section
Special Emphasis Panel (ZAR1-RJB-B (O1))
Program Officer
Panagis, James S
Project Start
2001-09-28
Project End
2003-07-31
Budget Start
2001-09-28
Budget End
2002-07-31
Support Year
1
Fiscal Year
2001
Total Cost
$68,360
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Dentistry
Type
Schools of Dentistry
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Schek, Rachel M; Taboas, Juan M; Segvich, Sharon J et al. (2004) Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds. Tissue Eng 10:1376-85
Schek, Rachel Maddox; Hollister, Scott J; Krebsbach, Paul H (2004) Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther 9:130-8
Taboas, J M; Maddox, R D; Krebsbach, P H et al. (2003) Indirect solid free form fabrication of local and global porous, biomimetic and composite 3D polymer-ceramic scaffolds. Biomaterials 24:181-94